Agenus competitive analysis

Explore patent oppositions filed by Agenus against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Combination Therapies Employing Gitr Binding MoleculesGITRMar 14, 2017
Compositions And Methods Of Identifying Tumor Specific NeoantigensDANA FARBER CANCER INSTITUTENov 9, 2016

Latest PTAB cases involving Agenus

Discover the latest PTAB cases involving Agenus, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Agenus with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AGENUS2 - - -
DANA FARBER CANCER INSTITUTE - 2531
GITR - 11 - -
THE GENERAL HOSPITAL - 36 - 2